Buscar en
Medicina Clínica (English Edition)
Toda la web
Inicio Medicina Clínica (English Edition) May-Thurner syndrome and deep vein thrombosis: A series of 8 patients
Journal Information
Vol. 156. Issue 12.
Pages 622-624 (June 2021)
Share
Share
Download PDF
More article options
ePub
Visits
0
Vol. 156. Issue 12.
Pages 622-624 (June 2021)
Clinical report
DOI: 10.1016/j.medcle.2020.11.020
May-Thurner syndrome and deep vein thrombosis: A series of 8 patients
Síndrome de May-Thurner y trombosis venosa profunda: estudio de ocho pacientes
Visits
...
Alejandra García-Garcíaa,b, Crhistian-Mario Oblitasa,b, Francisco Galeano-Vallea,b,c,
Corresponding author
paco.galeano.valle@gmail.com

Corresponding author.
, Andrea Olmos-Nietob, Ana Ortega-Soudantb, Pablo Demelo-Rodrígueza,b,c
a Venous Thromboembolism Unit, Internal Medicine. Hospital General Universitario Gregorio Marañón, Madrid, Spain
b Department of Medicine, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain
c Instituto de investigación sanitaria Gregorio Marañón, Madrid, Spain
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Tables (2)
Table 1. Clinical characteristics of patients with deep vein thrombosis and May-Thurner syndrome.
Table 2. Treatment and outcomes.
Show moreShow less
Abstract
Objectives

To analyze the prevalence of May-Thurner syndrome (MTS) among patients with deep vein thrombosis (DVT) of left lower limb (LLL), and outcomes after long-term follow-up.

Method

Retrospective observational study that included patients older than 18 diagnosed with acute DVT and MTS.

Results

Among 760 patients diagnosed with DVT in the LLL, 8 patients were diagnosed with MTS (1.05%), with a mean age of 39 years. All patients received long-term anticoagulation, with a mean of 31.9 (±25.2) months. Invasive treatment with pharmaco-mechanical thrombectomy was performed in 5 patients (62.5%). During follow-up (mean of 32.4 months), 25% of patients suffered DVT recurrence. Only 1 case presented major bleeding, and no deaths were registered.

Conclusions

May-Thurner syndrome constitutes a permanent and underdiagnosed risk factor for the development of DVT of LLL. Our findings suggest that long-term anticoagulation therapy might be considered in selected cases.

Keywords:
Deep venous thrombosis
May-Thurner syndrome
Thrombectomy
Anticoagulation
Resumen
Objetivos

Analizar la prevalencia del síndrome de May-Thurner (SMT) en una cohorte de pacientes con trombosis venosa profunda (TVP) en el miembro inferior izquierdo (MII), y las complicaciones durante el seguimiento a largo plazo.

Métodos

Estudio observacional retrospectivo que incluyó a pacientes mayores de 18 años con diagnóstico de TVP en el MII y SMT.

Resultados

Entre los 760 pacientes diagnosticados de TVP en el MII, ocho pacientes fueron diagnosticados de SMT (1,05%), con una media de edad de 39 años. Todos los pacientes recibieron tratamiento anticoagulante a largo plazo, con una media de 31,9 (± 25,2) meses. Se realizó tratamiento invasivo con trombectomía fármaco-mecánica en cinco pacientes (62,5%). Durante el seguimiento (media de 32,4 meses), el 25% de los pacientes sufrieron recurrencia de TVP. Solo se registró un sangrado mayor y no se registraron muertes.

Conclusiones

El síndrome de May-Thurner constituye un factor de riesgo infradiagnosticado y permanente para el desarrollo de TVP en el MII. Nuestros hallazgos sugieren que la anticoagulación a largo plazo podría ser considerada en casos seleccionados.

Palabras clave:
Trombosis venosa profunda
Síndrome de May-Thurner
Trombectomía
Anticoagulación

Article

These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Medicina Clínica (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos